Peer-reviewed veterinary case report
Phacoemulsification eye surgery results in Boston terriers versus
By Newbold, Georgina M et al.·Published in Veterinary ophthalmology·2018·Department of Small Animal Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Phacoemulsification outcomes in Boston terriers as compared to non-Boston terriers: a retrospective study (2002-2015).
- Species:
- dog
Plain-English summary
A group of 35 Boston terriers underwent eye surgery called phacoemulsification to treat cataracts, and researchers looked at how well they could see afterward compared to other breeds. After one year, about 17% of the Boston terriers lost their vision, while 12% of non-Boston terriers experienced the same issue. By the two-year mark, the vision loss rates were similar for both groups, with glaucoma being the main reason for the loss of sight. Overall, the surgery was successful for about 80-90% of dogs in the first year, but this dropped to 65-80% by the second year.
People also search for: Boston terrier eye surgery success · cataract surgery for dogs · glaucoma in dogs treatment
Abstract
OBJECTIVES: To compare visual outcome and cause of blindness between two groups of dogs undergoing phacoemulsification. ANIMALS STUDIED: Study population consisted of 35 Boston terriers (BT; 70 eyes) and 77 non-Boston terriers (NBT; 154 eyes) that underwent bilateral phacoemulsification surgery. PROCEDURES: Medical records were reviewed to determine visual outcome, complications leading to blindness and follow-up. A Kaplan-Meier survival curve was used to estimate surgical success at 1 and 2 years postoperatively. RESULTS: Eleven of 35 BT developed known vision loss, with 12 of 70 (17.1%) eyes becoming blind within one year of surgery, and 17 of 77 NBT developed known vision loss, with 19 of 154 (12.3%) eyes becoming blind within 1 year of surgery. No further vision loss was reported among those BT with a 2-year follow-up. In the NBT group, seven additional dogs, a total of 24 of 77 NBT developed vision loss, with a known total of 31 of 154 (20.1%) eyes becoming blind within two years of surgery. These results were not significantly different. The overall surgical success in both groups based on individual eyes was estimated to be between 80 and 90% at 1 year postsurgery and between 65 and 80% at 2 years postsurgery. Glaucoma was the leading cause of vision loss in both groups. CONCLUSIONS: There was no significant difference in visual outcomes between a group of BT and a group of NBT undergoing bilateral phacoemulsification at the University of Tennessee between 2002 and 2015. Glaucoma was the leading cause of vision loss in both groups.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/29380923/